Anraku K - Search Results

1

Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.

Sakuma M, Toyoda S, Arikawa T, Koyabu Y, Kato T, Adachi T, Suwa H, Narita JI, Anraku K, Ishimura K, Yamauchi F, Sato Y, Inoue T. Sakuma M, et al. Among authors: anraku k. PLoS One. 2022 Jan 25;17(1):e0261445. doi: 10.1371/journal.pone.0261445. eCollection 2022. PLoS One. 2022. PMID: 35077456 Free PMC article. Clinical Trial.

2

The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.

Sakuma M, Toyoda S, Arikawa T, Koyabu Y, Kato T, Adachi T, Suwa H, Narita JI, Anraku K, Ishimura K, Yamauchi F, Sato Y, Inoue T; For Excited UA study Investigators. Sakuma M, et al. Among authors: anraku k. Clin Exp Nephrol. 2018 Dec;22(6):1379-1386. doi: 10.1007/s10157-018-1599-6. Epub 2018 Jun 18. Clin Exp Nephrol. 2018. PMID: 29916098

3

Optimal uric acid reduction to improve vascular endothelial function in patients with chronic heart failure complicated by hyperuricemia.

Naganuma J, Sakuma M, Kitahara K, Kato T, Yokomachi J, Yamauchi F, Inoue R, Iida K, Kohno Y, Inoue K, Koshiji N, Abe S, Toyoda S, Inoue T; Excited UA study investigators. Naganuma J, et al. Hypertens Res. 2023 Mar;46(3):688-696. doi: 10.1038/s41440-022-01116-7. Epub 2022 Dec 20. Hypertens Res. 2023. PMID: 36539463

4

A water-soluble luminescent tris(2,4,6-trichlorophenyl)methyl radical-carbazole dyad.

Anraku K, Matsuda K, Miyata S, Ishii H, Hosokai T, Okada S, Nakamura K, Nakao K, Albrecht K. Anraku K, et al. J Mater Chem B. 2024 Jul 17;12(28):6840-6846. doi: 10.1039/d4tb00940a. J Mater Chem B. 2024. PMID: 38913346

5

HIV-1 Gag MA domain binds to cardiolipin in a binding mode distinct from virus assemble mediator PI(4,5)P₂.

Tateishi H, Chinen T, Fukuda R, Radwan MO, Shimagaki K, Koga R, Masuda T, Okamoto Y, Sakamoto A, Misumi S, Otsuka M, Fujita M, Anraku K. Tateishi H, et al. Among authors: anraku k. Chem Biol Drug Des. 2024 Jan;103(1):e14401. doi: 10.1111/cbdd.14401. Epub 2023 Nov 20. Chem Biol Drug Des. 2024. PMID: 37985015

6

Effects of halogen atom substitution on luminescent radicals: a case study on tris(2,4,6-trichlorophenyl)methyl radical-carbazole dyads.

Nakamura K, Matsuda K, Xiaotian R, Furukori M, Miyata S, Hosokai T, Anraku K, Nakao K, Albrecht K. Nakamura K, et al. Among authors: anraku k. Faraday Discuss. 2024 Mar 11;250(0):192-201. doi: 10.1039/d3fd00130j. Faraday Discuss. 2024. PMID: 37966049

7

Performance Characteristics of a New-Generation Digital Bismuth Germanium Oxide PET/CT System, Omni Legend 32, According to NEMA NU 2-2018 Standards.

Yamagishi S, Miwa K, Kamitaki S, Anraku K, Sato S, Yamao T, Kubo H, Miyaji N, Oguchi K. Yamagishi S, et al. Among authors: anraku k. J Nucl Med. 2023 Dec 1;64(12):1990-1997. doi: 10.2967/jnumed.123.266140. J Nucl Med. 2023. PMID: 37857503 Free article.

8

Significance of Circulating Remnant Lipoprotein Cholesterol Levels Measured by Homogeneous Assay in Patients with Type 2 Diabetes.

Matsushima-Nagata K, Matsumura T, Kondo Y, Anraku K, Fukuda K, Yamanaka M, Manabe M, Irie T, Araki E, Sugiuchi H. Matsushima-Nagata K, et al. Among authors: anraku k. Biomolecules. 2023 Mar 3;13(3):468. doi: 10.3390/biom13030468. Biomolecules. 2023. PMID: 36979403 Free PMC article.

9

Photostability of luminescent tris(2,4,6-trichlorophenyl)methyl radical enhanced by terminal modification of carbazole donor.

Matsuda K, Xiaotian R, Nakamura K, Furukori M, Hosokai T, Anraku K, Nakao K, Albrecht K. Matsuda K, et al. Among authors: anraku k. Chem Commun (Camb). 2022 Dec 6;58(97):13443-13446. doi: 10.1039/d2cc04481a. Chem Commun (Camb). 2022. PMID: 36373670

10

Development of chimeric receptor activator of nuclear factor-kappa B with glutathione S-transferase in the extracellular domain: Artificial switch in a membrane receptor.

Kawashima K, Hirota-Tsukimachi M, Toma T, Koga R, Iwamaru K, Kanemaru Y, Yanae M, Ahagon A, Nakamura Y, Anraku K, Tateishi H, Gohda J, Inoue JI, Otsuka M, Fujita M. Kawashima K, et al. Among authors: anraku k. Chem Biol Drug Des. 2022 Apr;99(4):573-584. doi: 10.1111/cbdd.14002. Epub 2021 Dec 19. Chem Biol Drug Des. 2022. PMID: 34882966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters